From Name:
From Email:
To Name:
To Email:

Optional Message:

NIH Grants License Agreement for Candidate Ebola Vaccines

from National Institutes of Health via

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has announced a new license agreement aimed at advancing dual-purpose candidate vaccines to protect against rabies and Ebola viruses. The vaccines were created by scientists at NIAID and Thomas Jefferson University in Philadelphia and are being further developed through a partnership with the German pharmaceutical company IDT Biologika. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063